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− Nigericin

Abstract / Introduction

• NLRP3KO: mouse macrophage NLRP3 and ASC knock-out cell line
transfected with a murine NLRP3 FLAG-GFP construct and a human ASCmCerulean construct.
• Rapid growth required passage every other day.
• Imaging and particle studies used soluble activator nigericin at 5 µM as a
positive control and particles were at a concentration of 25 µg/mL.
• Confocal microscopy at 60X using HCS NuclearMask Red nuclear stain
• Cell viability was determined with LDH and MTS assays. IL-1β production
assay performed by ELISA.
• Expression of ASC and NLRP3 constructs checked by Western Blot.
• Cholesterol modifier treatment: U18666A 24 hour incubation at 1 μM,
MbCD 1 hour incubation at 10 μM in serum-free media, imipramine 4
hour incubation at 25 μM.
•

Particles: Montmorillonite (MMT), purified C2 multi-walled carbon nanotubes (MWCNT), Crocidolite (CRO),
Crystalline Silica (CSiO₂), Amorphous Silica (ASiO₂), Titanium Nanobelts (TNB), Titanium Nanospheres (TNS),
Nonpurified C4 MWCNT (C4)

No Treatment

• NLRP3KO cells overexpress
inflammasome proteins NALP3 and ASC
(Figure 1)
• Treatment of NLRP3KO cells with
cholesterol modifiers U18666A, MbCD
and imipramine induces heightened
sensitivity to inflammasome formation
in the presence of nigericin (Figure 2)

U18666A

• Lysotracker Red stain indicated loss of
lysosomes in NLRP3KO cells in presence
of nanoparticles and nigericin (Figure 3)
Figure 4: Cell viability and
IL-1β production assays for
nanoparticle-treated
NLRP3KO cells

Results
Figure 2: NLRP3KO cells with cholesterol-trafficking modifiers +/- nigericin.
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Figure 1: NLRP3KO cell line expression of A) Human ASC mCerulean (45 kDa) and
B) NLRP3- FLAG GFP protein (118 kDa) constructs compared to normal
expression in two mouse models and THP-1 cells.

• Cell viability and IL-1β assays indicate
NLRP3KO cells respond to nanoparticles
differently and in a dosage-dependent
manner (Figure 4)

Discussion and Conclusions

MbCD

Materials and Methods

• Fluorescent inflammasome complex
assembly increases in a dosagedependent manner to nigericin (Not
shown)

NLRP3
ASC
NuclearMask

Imipramine

Lysosomal Membrane Permeablization (LMP) is known to cause
programmed cell death. LMP releases hydrolytic enzymes from the
endosomal compartments of cells, initiating the production of reactive
oxygen species (ROS) and downstream signals resulting in cell death.
Certain endosome enzymes, such as cathepsins, are associated with the
formation of a large multi-protein complex called the inflammasome.
Inflammasome formation leads to subsequent activation of caspase-1, the
release of pro-inflammatory cytokines from cells and cell death by
pyroptosis. In recent years, many studies have suggested that altering
cholesterol levels in lysosomes can affect the severity of LMP and ensuing
cell death. In this study, we used three drugs thought to have opposing
effects on cholesterol trafficking in the endosomal compartments. U18666A
and imipramie are thought to impede cholesterol trafficking in the
endosomal compartments, causing accumulation in membranes and
hindering LMP and cell death. Methyl β-cyclodextrin (MbCD), a cholesterolchelating drug, is thought to extract cholesterol from cells, increasing
sensitivity to LMP. We used NLRP3KO cells to visualize inflammasome
formation with nanomaterials known to induce LMP in certain cell lines in
the presence of these drugs. Along with testing effects of cholesterol
modifiers on the NLRP3KO cell line, we attempted to optimize the
conditions for utilizing these cells as a model for inflammasome formation
and inflammation by nanoparticles by performing dosage response tests to
nanoparticles using cell viability and IL-1β production assays, conducting a
time course response to particulates to determine a timeline for
inflammasome activation, and endeavoring to create a protocol for
quantifying inflammasome formation in particle-treated cells.

+ Nigericin
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Figure 3: NLRP3KO cells with Lysotracker Red to visualize lysosomes. Control
cells (A), and cells treated with TNB (B) and nigericin (C).

• NLRP3KO cells are useful for visualizing inflammasome formation
because fluorescent NLRP3 and ASC come together in an identifiable
bright spot
• IL-1β production is linked to inflammasome formation. Some
nanoparticles activate inflammasome assembly
• NLRP3KO cells are not the best model for studies using nanoparticles,
but respond well to soluble activators
• Cholesterol-trafficking modifiers greatly affect inflammasome activation
in NLRP3KO cells
• All three drugs increase inflammasome activation with nigericin
• MbCD chelates cholesterol, decreasing availability for lysosome
membranes and causing LMP
• U18666A was not protective against inflammasome activation as
hypothesized. Studies have suggested it leads to accumulation of
intracellular oxidized cholesterol crystals, inducing TNFα and ROS to
activate inflammasomes and IL-1β production
• Other studies based conclusions on mRNA and protein assays, not
direct inflammasome visualization.
• MbCD and U18666A increased inflammasome activation in absence
of nigericin, suggesting NLRP3KO cells are very sensitive to
cholesterol disturbances, possibly due to overexpression of
inflammasome proteins.
• Future directions: Further understanding of mechanisms of cholesteroltrafficking modification in NLRP3KO cells and the role of cathepsin B in
inflammasome activation

Literature Cited
Appelqvist H, et al. 2012. Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal
cholesterol content. PLOS ONE 7(11): 1-11.
Iftakhar-E-Khuda I, et al. 2009. Novel mechanism of U18666A-induced tumour necrosis factor-α production in
RAW 264.7 macrophage cells. Clinical & Experimental Immunology 155(3): 552-558.
Rajamäki K, et al. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel l
ink between cholesterol metabolism and inflammation. PLOS ONE 5(7): 1-9.

Acknowledgements
Thank you to Dr. Andrij Holian, Raymond Hamilton, Lou Herritt, Pamela Shaw
C2, C4, TNB, and TNS particles courtesy of Nick Wu (WVU)

